Literature DB >> 1717947

Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin.

K Yoshimura1, H Nakamura, B C Trapnell, C S Chu, W Dalemans, A Pavirani, J P Lecocq, R G Crystal.   

Abstract

Consistent with the fact that the clinical disorder cystic fibrosis (CF) is manifested on epithelial surfaces, active transcription of the CF transmembrane conductance regulator (CFTR) gene and CFTR mRNA transcripts are detectable in a variety of epithelial cells, suggesting CFTR gene expression might be epithelial cell-specific. However, analysis of the CFTR gene promoter suggests it is a housekeeping gene, implying more widespread expression than only in epithelial cells. To evaluate the latter hypothesis, various human cells of non-epithelial origin, including lung fibroblasts, U-937 histiocytic lymphoma cells, K-562 erythroleukemia cells, HL-60 promyelocytic leukemia cells as well as freshly isolated blood lymphocytes, neutrophils, monocytes, and alveolar macrophages were examined for CFTR gene expression. Although Northern analysis failed to show CFTR mRNA transcripts in these cells, amplification of mRNA (after conversion to cDNA) by polymerase chain reaction combined with Southern analysis demonstrated the presence of CFTR mRNA transcripts at low levels in all cells evaluated except HL-60 cells. Comparative quantitative analysis showed fibroblasts contained 200-400 fold less CFTR mRNA transcripts than the T84 and HT-29 colon carcinoma epithelial cell lines, but had similar levels of CFTR transcripts to those of other epithelial cell lines. Nuclear transcription run-on analyses demonstrated very low level CFTR gene transcription in fibroblasts and U-937 cells, similar to that of other epithelial cells, but lower than the T84 and HT-29 colon carcinoma cell lines. Interestingly, while chromatin DNA of fibroblasts had no DNase I hypersensitivity sites in the 5' flanking region of the CFTR gene, HT-29 chromatin DNA exhibited four DNase I accessible sites in the same region, suggesting that these sites may be related to more active transcription of the CFTR gene in the intestinal epithelial cells than in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717947      PMCID: PMC328907          DOI: 10.1093/nar/19.19.5417

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium.

Authors:  M Li; J D McCann; C M Liedtke; A C Nairn; P Greengard; M J Welsh
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

3.  Identification of a defective cAMP-stimulated Cl- channel in cystic fibrosis fibroblasts.

Authors:  P Y Lin; E Gruenstein
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

4.  Proton pumps and chloride channels in secretory vesicles.

Authors:  Q al-Awqati; J Barasch; D W Landry
Journal:  Soc Gen Physiol Ser       Date:  1989

5.  A cAMP-regulated chloride channel in lymphocytes that is affected in cystic fibrosis.

Authors:  J H Chen; H Schulman; P Gardner
Journal:  Science       Date:  1989-02-03       Impact factor: 47.728

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Secretion of antileucoprotease from a human lung tumor cell line.

Authors:  B Appelhans; B Ender; G Sachse; T Nikiforov; H Appelhans; W Ebert
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

8.  Cystic fibrosis and beta-adrenergic response of airway epithelial cell cultures.

Authors:  J H Widdicombe
Journal:  Am J Physiol       Date:  1986-10

9.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Cl- channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase.

Authors:  T C Hwang; L Lu; P L Zeitlin; D C Gruenert; R Huganir; W B Guggino
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

View more
  67 in total

1.  Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7.

Authors:  H Davidson; M S Taylor; A Doherty; A C Boyd; D J Porteous
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

2.  Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.

Authors:  Christian Mueller; Sofia A Braag; Allison Keeler; Craig Hodges; Mitchell Drumm; Terence R Flotte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

3.  Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation.

Authors:  S Vuillaumier; I Dixmeras; H Messaï; C Lapouméroulie; D Lallemand; J Gekas; F F Chehab; C Perret; J Elion; E Denamur
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages.

Authors:  Amanda G Kostyk; Karen M Dahl; Murry W Wynes; Laurie A Whittaker; Daniel J Weiss; Roberto Loi; David W H Riches
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

5.  Generation of a conditional null allele for Cftr in mice.

Authors:  Craig A Hodges; Calvin U Cotton; Mark R Palmert; Mitchell L Drumm
Journal:  Genesis       Date:  2008-10       Impact factor: 2.487

Review 6.  Salt, chloride, bleach, and innate host defense.

Authors:  Guoshun Wang; William M Nauseef
Journal:  J Leukoc Biol       Date:  2015-06-05       Impact factor: 4.962

7.  Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor.

Authors:  Preston E Bratcher; Steven M Rowe; Ginger Reeves; Tambra Roberts; Tomasz Szul; William T Harris; Rabindra Tirouvanziam; Amit Gaggar
Journal:  J Cyst Fibros       Date:  2015-03-11       Impact factor: 5.482

Review 8.  Interactions of connexins with other membrane channels and transporters.

Authors:  Marc Chanson; Basilio A Kotsias; Camillo Peracchia; Scott M O'Grady
Journal:  Prog Biophys Mol Biol       Date:  2007-03-14       Impact factor: 3.667

9.  Assessment of arylamine N-acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients.

Authors:  A E Cribb; B Tsui; R Isbrucker; R T Michael; C T Gillespie; J Brown-Bonomo; P Barrett; T Levatte; K W Renton
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.